NHS South of England Branded Medicines - Tranche A - September 2023

Concepts

• nhs south of england branded medicines
• runcorn
• pharmaceutical products
• offer reference number
• england
• 01 - nhs framework
• 03 - nhs framework agreement
• 02 - nhs framework
• september
• nhs south of england branded medicines - tranche a

Location

Description

NHS South of England Branded Medicines - Tranche A - September 2023 Offer reference number: CM/PHR/22/5676 CM/PHR/22/5676/01 - NHS Framework for South of England Branded Medicines - Tranche A. Period of framework: 1 September 2023 to 31 August 2025 with an option or options to extend (at the Authority's discretion) for a period or periods up to a total of 24 months. CM/PHR/22/5676/02 - NHS Framework for South of England Branded Medicines - Annual Tranche. Period of framework: 1 September 2023 to 31 August 2024 with an option or options to extend (at the Authority's discretion) for a period or periods up to a total of 12 months. CM/PHR/22/5676/03 - NHS Framework Agreement for the supply of Risankizumab for the Midlands & East and North of England. Period of framework: 1 September 2023 to 29 February 2024 with an option or options to extend (at the Authority's discretion) for a period or periods up to a total of 12 months.

CPV Codes

• 33600000 - Pharmaceutical products

Indicators

• Contract is suitable for SMEs.

Other Information

Document No. 02 - Terms of offer CM_PHR_22_5676 Document No. 02 - Terms of offer CM_PHR_22_5676.docx Document No. 05a - Selectt Offer schedule - CM_PHR_22_5676_01 Document No. 05a - Selectt Offer schedule - CM_PHR_22_5676_01.xml Document No. 05a - Selectt Offer schedule - CM_PHR_22_5676_03 Document No. 05a - Selectt Offer schedule - CM_PHR_22_5676_03.xml Document No. 05b (i) - Tender Product listing and usage CM_PH_22_5676_01 Document No. 05b (i) - Tender Product listing and usage CM_PH_22_5676_01.xlsx Document No. 07a - Quality control technical sheet CM_PHR_22_5676 Document No. 07a - Quality control technical sheet CM_PHR_22_5676.pdf Document No. 01 - Invitation to offer covering letter CM_PHR_22_5676 Document No. 01 - Invitation to offer covering letter CM_PHR_22_5676.docx Document No. 05b (iii) - Tender Product listing and usage CM_PH_22_5676_03 Document No. 05b (iii) - Tender Product listing and usage CM_PH_22_5676_03.xlsx Document No. 03 - Framework Agreement and Terms and Conditions CM_PHR_22_5676 Document No. 03 - Framework Agreement and Terms and Conditions CM_PHR_22_5676.docx Document No. 05a - Selectt Offer schedule - CM_PHR_22_5676_02 Document No. 05a - Selectt Offer schedule - CM_PHR_22_5676_02.xml Document No. 09 - Tender design and instructions on completing the offer schedule CM_PHR_22_5676 Document No. 09 - Tender design and instructions on completing the offer schedule CM_PHR_22_5676.doc Document No. 05 - Selectt offer schedule instructions CM_PHR_22_5676 Document No. 05 - Selectt offer schedule instructions CM_PHR_22_5676.docx Document No. 05b (ii) - Tender Product listing and usage CM_PH_22_5676_02 Document No. 05b (ii) - Tender Product listing and usage CM_PH_22_5676_02.xlsx Document No. 05c - Volume discounts or Additional Products Offer Schedule Document No. 05c - Volume discounts or Additional Products Offer Schedule.xls Document No. 06 - Form of offer CM_PHR_22_5676 Document No. 06 - Form of offer CM_PHR_22_5676.doc Document No. 08 - Confidential information schedule CM_PHR_22_5676 Document No. 08 - Confidential information schedule CM_PHR_22_5676.xls Document No. 10 - Pharmacy Purchasing Points List CM_PHR_22_5676 Document No. 10 - Pharmacy Purchasing Points List CM_PHR_22_5676.xlsx Document No. 07b - Quality Assurance Policy to support the National Contract Procurement of Licensed Medicines - Edition 5.1 September 2022 CM_PHR_22_5676 Document No. 07b - Quality Assurance Policy to support the National Contract Procurement of Licensed Medicines - Edition 5.1 September 2022 CM_PHR_22_5676.pdf Document No. 04a - Quality Assurance Process CM_PHR_22_5676 Document No. 04a - Quality Assurance Process CM_PHR_22_5676.pdf Document No. 04b - Assessment Criteria, Stability Protocol and Additional Specification Requirements CM_PHR_22_5676 Document No. 04b - Assessment Criteria, Stability Protocol and Additional Specification Requirements CM_PHR_22_5676.pdf